Event/Webinar
Exploring Oncology Precision Medicine Landscape
On-Demand
View all IQVIA events

Precision medicine is rapidly gaining prominence as a mainstream treatment approach in oncology. Coupled with the rise of precision medicine, oncology has also seen biomarker tests not just entering the mainstream but also shifting the way decisions are made.

Join us as we explore current trends and insights with the evolving landscape of precision medicine and biomarker testing and its impact on oncology markets across different tumor types and geographies.

3 key takeaways:

  • Understand the complex market landscape of precision medicine therapies and biomarker testing.
  • Explore how biomarkers are tracked using IQVIA’s syndicated oncology offering.
  • Explore genomics in the immuno-oncology landscape.

Don't miss this opportunity to gain valuable knowledge and explore the frontiers of precision medicine in oncology. Secure your spot today!

Speakers

Vladimir Bonevski, Associate Director, Global Oncology Product & Strategy, IQVIA

Kriti Jindal, M.S. (Pharm.), Client Service Manager, Global Oncology, IQVIA

Lien Lybaert, Chief Development Officer, myNEO Therapeutics

Related solutions

Contact Us